Amryt Pharmaceuticals Inc, based in Boston, MA, is a leading global rare disease company dedicated to acquiring, developing, and commercializing innovative medicines that transform the lives of patients and their families worldwide. With a focus on rare, debilitating conditions, Amryt Pharma combines scientific expertise and bold innovation to provide hope and new treatment options for those in greatest need.
Through advocacy and a commitment to patient care, Amryt Pharma collaborates with advocacy groups to support patients and their caregivers. The company's vision is to be at the forefront of rare disease treatment, delivering impactful solutions that make a difference in the lives of individuals affected by conditions such as homozygous familial hypercholesterolaemia, lipodystrophy, and epidermolysis bullosa.
Generated from the website